Medical Countermeasures

Transcript, Meeting 11, Session 7

SESSION 7: MEMBER DISCUSSION

DR. GUTMANN:  Welcome back everybody.  We have until 11:45, right?  Great.  So, we'll take an hour and then wrap up. 

Date

Tue, 11/06/2012

Transcript, Meeting 11, Session 4

SESSION 4: ROUNDTABLE DISCUSSION

DR. WAGNER: We appreciate you all hanging around for a roundtable.  We have found these to be, uh, uh, very helpful, uh, although they tend to be extremely wide ranging and, uh, and I’m concerned that there isn’t – we try – in order to keep them from just going, spinning immediately out of control, we try to, uh, pose a framing question.  It’s very hard to pose a framing question for this one but, maybe we can start with something like this.

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 2

SESSION 2: MEDICAL COUNTERMEASURE (MCM) DISTRIBUTION

DR. WAGNER:  Let me invite our next session, experts forward, Bruce Lockwood, Dr. Benjamin. 

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 1

DR. WAGNER:  I believe we are assembled. I’m Jim Wagner.  It’s my privilege to be serving Emory University as its president.  I also am privileged to be the Vice Chair of this President’s Commission on the Study of Bioethical Issues.  Our chairman, Amy Gutmann, has asked me to convey, uh, regrets, at least for this first day of our meetings.  She had something come up on Saturday, uh which obligates her today and requires her attention today, but she’ll be flying in I believe this evening to be with us tomorrow.

Date

Mon, 11/05/2012

Pages

Subscribe to RSS - Medical Countermeasures

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.